v3.25.2
Note 3 - Restatement of Previously Issued Consolidated Financial Statements (as Restated) - Statements of Cash Flows (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2024
Sep. 30, 2024
Jun. 30, 2024
Sep. 30, 2023
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Net income   $ (270) $ (3,443) $ 1,098 $ 1,106 $ 3,737 $ 2,883 $ 3,468 $ 3,981 $ (2,687) $ 4,776  
Depreciation and amortization           926 941 1,380 1,438 1,553 1,827  
Amortization of operating lease assets           310 256 415 433 545 875  
Provision for expected credit losses           89 38 133 138 128 88  
Deferred income tax expense/(benefit)           1,349 2,218 4,577 (638) (1,500) 1,258  
Share based compensation           256 134 107 217 137 297  
(Gain) loss on disposal of business   960 1,411 0 0 (5,746) 0 (4,786)   (2,536) 408  
Accounts receivable           (6,199) 2,525 (2,276) (1,978) (2,089) 246  
Prepaid expenses and other assets           171 (2,142) 408 (1,630) 416 (1,350)  
Accounts payable           2,493 (552) 4,333 684 7,459 (2,010)  
Operating lease liabilities           (310) (256) (415) (433) (541) (875)  
Accrued expenses, other current liabilities and customer incentives and deposits           1,213 427 (7,648) (1,522) (1,124) (1,919)  
Net cash (used in) provided by operating activities of continuing operations           596 6,472 (304) 690 (239) 3,621  
Net cash (used in) provided by operating activities of discontinued operations           (426) 272 (426) 950 (426) 3,200  
Net cash (used in) provided by operating activities           170 6,744 (730) 1,640 (665) 6,821  
Proceeds from sale of joint ventures, net of cash transferred                   7,259 (1,067)  
Purchases of property and equipment and internal use software           (771) (694) (898) (1,037) (1,129) (1,194)  
Net cash provided by (used in) investing activities of continuing operations           7,211 (694) 5,777 (1,037) 6,130 (2,261)  
Net cash provided by (used in) investing activities of discontinued operations           3,751 (23) 3,751 (46) 3,751 (8)  
Net cash provided by (used in) investing activities           10,962 (717) 9,528 (1,083) 9,881 (2,269)  
Borrowings under lines of credit           69,117 47,340 103,184 80,151 132,133 103,742  
Repayments under lines of credit           (64,044) (50,003) (97,782) (79,520) (128,347) (104,845)  
Payment of notes to seller           (1,843)   (1,843)   (1,843) 0  
Repurchase of common stock           (1,800)   (1,800)   (1,800) 0  
Distribution to non-controlling investors           0 0 0 (427) 0 (426)  
Payments to acquire noncontrolling interests           (250)   (250) (473) (500) (473)  
Proceeds from long-term debt                   15 930  
Net cash used in financing activities of continuing operations           1,206 (3,136) 1,525 (269) (341) (1,773)  
Net cash used in financing activities of discontinued operations           (1,315) (1,196) (1,315) (1,247) (1,315) (1,247)  
Net cash used in financing activities           (109) (4,332) 210 (1,516) (1,656) (3,020)  
Effect of foreign exchange rate changes on cash           (48) (124) (75) (426) (58) (158)  
Net increase in cash and cash equivalents           10,976 1,571 8,933 (1,385) 7,502 1,374  
Cash and cash equivalents at beginning of year $ 19,652 21,695       10,719 9,345 10,719 9,345 10,719 9,345  
Cash and cash equivalents at end of year 18,221 19,652 21,695     21,695   19,652   18,221 10,719  
Less cash and cash equivalents of discontinued operations 0     3,081 1,815   1,815   3,081 0 6,228  
Cash and cash equivalents from continuing operations 18,221     4,879 9,101   9,101   4,879 18,221 4,491 $ 9,345
Payments on term debt                   0 (701)  
Previously Reported [Member]                        
Net income   (232) 4,075 1,098 1,106 11,255 2,883 11,024 3,981 (2,687) 4,776  
Depreciation and amortization           989 1,026 1,443 1,574 1,616 2,001  
Amortization of operating lease assets           310 256 415 433 545 875  
Provision for expected credit losses           89 38 133 138 128 88  
Deferred income tax expense/(benefit)           1,349 111 4,577 (15) (1,500) 921  
Share based compensation           256 134 107 217 137 297  
(Gain) loss on disposal of business   922 (4,919) 0 0 (12,076) 0 (11,154)   (1,348) 408  
Accounts receivable           (9,766) 1,205 (5,843) (1,963) (5,656) 3,232  
Prepaid expenses and other assets           (2,620) 3,118 (2,383) 1,635 (2,375) 2,082  
Accounts payable           1,992 (803) 3,832 409 6,958 (2,960)  
Operating lease liabilities           (310) (256) (415) (433) (541) (875)  
Accrued expenses, other current liabilities and customer incentives and deposits           6,395 (968) (2,466) (4,336) 4,058 (4,024)  
Net cash (used in) provided by operating activities of continuing operations           170 6,744 (730) 1,640 (665) 6,821  
Net cash (used in) provided by operating activities of discontinued operations           0 0 0 0 0 0  
Net cash (used in) provided by operating activities           170 6,744 (730) 1,640 (665) 6,821  
Proceeds from sale of joint ventures, net of cash transferred                   11,020 (1,027)  
Purchases of property and equipment and internal use software           (781) (717) (908) (1,083) (1,139) (1,242)  
Net cash provided by (used in) investing activities of continuing operations           10,962 (717) 9,528 (1,083) 9,881 (2,269)  
Net cash provided by (used in) investing activities of discontinued operations           0 0 0 0 0 0  
Net cash provided by (used in) investing activities           10,962 (717) 9,528 (1,083) 9,881 (2,269)  
Borrowings under lines of credit           69,117 47,340 103,184 80,151 132,133 103,742  
Repayments under lines of credit           (64,044) (50,003) (97,782) (79,520) (128,347) (104,845)  
Payment of notes to seller           (1,843)   (1,843)   (1,843) 0  
Repurchase of common stock           (1,800)   (1,800)   (1,800) 0  
Distribution to non-controlling investors           (1,315) (1,196) (1,315) (1,674) (1,315) (1,673)  
Payments to acquire noncontrolling interests           (250)   (250) (473) (500) (473)  
Proceeds from long-term debt                   15 930  
Net cash used in financing activities of continuing operations           (109) (4,332) 210 (1,516) (1,657) (3,020)  
Net cash used in financing activities of discontinued operations           0 0 0 0 0 0  
Net cash used in financing activities           (109) (4,332) 210 (1,516) (1,657) (3,020)  
Effect of foreign exchange rate changes on cash           (48) (124) (75) (426) (58) (158)  
Net increase in cash and cash equivalents           10,976 1,571 8,933 (1,385) 7,502 1,374  
Cash and cash equivalents at beginning of year 19,652 21,695       10,719 9,345 10,719 9,345 10,719 9,345  
Cash and cash equivalents at end of year 18,221 19,652 21,695     21,695   19,652   18,221 10,719  
Less cash and cash equivalents of discontinued operations 0     (0) (0)   (0)   (0) 0 0  
Cash and cash equivalents from continuing operations 18,221     7,960 10,916   10,916   7,960 18,221 10,719 9,345
Payments on term debt                     (701)  
Revision of Prior Period, Adjustment [Member]                        
Net income   (38) (7,518) 0 0 (7,518) 0 (7,556) 0 0 0  
Depreciation and amortization           0 (85) 0 (136) (63) (174)  
Amortization of operating lease assets           0 0 0 0 0 0  
Provision for expected credit losses           0 0 0 0 0 0  
Deferred income tax expense/(benefit)           0 2,107 0 (623) 0 337  
Share based compensation           0 0 0 0 0 0  
(Gain) loss on disposal of business   38 7,518 0 0 7,518 0 7,556   (1,188) 0  
Accounts receivable           0 1,320 0 (15) 3,567 (2,986)  
Prepaid expenses and other assets           0 (5,260) 0 (3,265) 2,791 (3,432)  
Accounts payable           0 251 0 275 501 950  
Operating lease liabilities           0 0 0 0 0 0  
Accrued expenses, other current liabilities and customer incentives and deposits           0 1,395 0 2,814 (5,182) 2,105  
Net cash (used in) provided by operating activities of continuing operations           0 (272) 0 (950) 426 (3,200)  
Net cash (used in) provided by operating activities of discontinued operations           0 272 0 950 (426) 3,200  
Net cash (used in) provided by operating activities           0 0 0 0 0 0  
Proceeds from sale of joint ventures, net of cash transferred                   (3,761) (40)  
Purchases of property and equipment and internal use software           0 23 0 46 10 48  
Net cash provided by (used in) investing activities of continuing operations           0 23 0 46 (3,751) 8  
Net cash provided by (used in) investing activities of discontinued operations           0 (23) 0 (46) 3,751 (8)  
Net cash provided by (used in) investing activities           0 0 0 0 0 0  
Borrowings under lines of credit           0 0 0 0 0 0  
Repayments under lines of credit           0 0 0 0 0 0  
Payment of notes to seller           0   0   0 0  
Repurchase of common stock           0   0   0 0  
Distribution to non-controlling investors           0 1,196 0 1,247 1,315 1,247  
Payments to acquire noncontrolling interests           0   0 0 0 0  
Proceeds from long-term debt                   0  
Net cash used in financing activities of continuing operations           0 1,196 0 1,247 1,315 1,247  
Net cash used in financing activities of discontinued operations           0 (1,196) 0 (1,247) (1,315) (1,247)  
Net cash used in financing activities           0 0 0 0 0 0  
Effect of foreign exchange rate changes on cash           0 0 0 0 0 0  
Net increase in cash and cash equivalents           0 0 0 0 0 0  
Cash and cash equivalents at beginning of year 0 0       0 0 0 0 0 0  
Cash and cash equivalents at end of year 0 $ 0 $ 0     $ 0   $ 0   0 0  
Less cash and cash equivalents of discontinued operations 0     3,081 1,815   1,815   3,081 0 6,228  
Cash and cash equivalents from continuing operations $ 0     $ 0 $ 0   $ 0   $ 0 $ 0 (6,228)
Payments on term debt                     $ 0